Identifying potential pathogenesis and immune infiltration in diabetic foot ulcers using bioinformatics and in vitro analyses.

Authors:
Xu Y; Xu J; Chen S; Zhou A; Huang G and 3 more

Journal:
BMC Med Genomics

Publication Year: 2023

DOI:
10.1186/s12920-023-01741-2

PMCID:
PMC10693102

PMID:
38041124

Journal Information

Full Title: BMC Med Genomics

Abbreviation: BMC Med Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the gse68184 and gse80178 data are available from geo. availability of data and materials publicly available datasets were analyzed in this study. the gse68184"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was conducted following the guidelines of the Declaration of Helsinki. All experiments were approved by the Medical Ethics Committee of Youjiang Medical University for Nationalities (approval number: 2018051501). All patients signed an informed consent form to acquire and use discarded tissue. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China [81960875], Innovation Project of Guangxi Graduate Education [YCSW2022456], Guangxi Natural Science Foundation [2018GXNSFAA281124], Project of Guangxi Administration of Traditional Chinese Medicine [20210672], and Project of Baise Scientific Research and Technological Development Plan [(2021) 23-11]."

Evidence found in paper:

"Trial registration The clinical trial included in this study was registered in the Chinese Clinical Trial Registry (ChiCTR2200066660) on December 13, 2022."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025